Dendritic cells as adjuvants for immune-mediated resistance to tumors

scientific article published on October 1997

Dendritic cells as adjuvants for immune-mediated resistance to tumors is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1084/JEM.186.8.1183
P932PMC publication ID2199101
P698PubMed publication ID9379142
P5875ResearchGate publication ID13851136

P50authorRalph SteinmanQ105494
P2093author name stringG Schuler
P2860cites workA Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaQ24319940
Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitopeQ24652858
Phenotypic analysis of antigen-specific T lymphocytesQ28290058
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factorQ29619247
Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growthQ73585686
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cellsQ34229490
Identification of proliferating dendritic cell precursors in mouse bloodQ36231236
Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunityQ36366130
A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosisQ36366458
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alphaQ36367113
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivoQ36367135
In vivo detection of dendritic cell antigen presentation to CD4(+) T cells.Q36377341
Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergyQ36380365
Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanismQ36380421
Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastasesQ36380718
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunityQ36380749
Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanomaQ36763316
Tumor antigens recognized by T lymphocytesQ40661131
Dendritic cells: from ignored cells to major players in T-cell-mediated immunityQ40899962
Origin, maturation and antigen presenting function of dendritic cells.Q40906220
Developmental regulation of MHC class II transport in mouse dendritic cells.Q41093187
The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor alpha spots in response to peptide antigensQ41115110
Identification of the genes encoding cancer antigens: implications for cancer immunotherapy.Q41196605
Fibroblasts as efficient antigen-presenting cells in lymphoid organsQ41336467
Capture and processing of exogenous antigens for presentation on MHC molecules.Q41464375
Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes backQ41465258
TAP off--tumors on.Q41504939
Functions of CD40 on B cells, dendritic cells and other cellsQ41514641
New insights into the mobilization and phagocytic activity of dendritic cellsQ42142211
A novel migration pathway for rat dendritic cells from the blood: hepatic sinusoids-lymph translocationQ43136015
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cellsQ46578425
Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody.Q52827100
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.Q54451826
CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysisQ57275941
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cellsQ57275942
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cellsQ59067424
Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitorQ60043767
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapyQ70840996
Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cellsQ71017514
TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitorsQ71403490
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsQ71607047
In vitro differentiation of CD34+ hematopoietic progenitor cells toward distinct dendritic cell subsets of the birbeck granule and MIIC-positive Langerhans cell and the interdigitating dendritic cell typeQ71611744
Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicabilityQ71615065
Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alphaQ71693365
Elevated serum levels of interleukin-10 in patients with metastatic malignant melanomaQ72203307
Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanomaQ73316641
Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cellsQ73321311
Flt3 ligand induces tumor regression and antitumor immune responses in vivoQ73400017
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibodyQ73479961
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectcellQ7868
cancerQ12078
dendritic cellQ506253
neoplasmQ1216998
biomedical investigative techniqueQ66648976
hemic and immune systemsQ70202933
adoptive immunotherapyQ72138716
P304page(s)1183-1187
P577publication date1997-10-01
1997-10-20
P1433published inJournal of Experimental MedicineQ3186912
P1476titleDendritic cells as adjuvants for immune-mediated resistance to tumors
P478volume186